中文版
英文版
Home
About us
About us
Company history
Company culture
Equipment
Chemical synthesis
Biological Mabs
Fermtation
Technology
Chemical synthesis
Biological Mabs
Products
Ophthalmology Series APIs
Prostaglandins APIs
Monoclonal Antibody APIs
Axitinib intermediate
Salmeterol intermediate
More competitive intermedites
Chiral catalyst
Vitmain D derivatives
Cell culture medium
News
Feedback
Contact us
Product Categories
Ophthalmology Series APIs
Prostaglandins APIs
Monoclonal Antibody APIs
Axitinib intermediate
Salmeterol intermediate
More competitive intermedites
Chiral catalyst
Vitmain D derivatives
Cell culture medium
5-Bromoacetyl-2-hydroxybenzaldehyde
6-N-Benzylamino-1-(4’-phenylbutoxy)Hexane
N-methyl-2-sulfanylbenzamide
(E)-3-[2-(Pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide
Products
Product
CAS No.
Purity
Bimatoprost
155206-00-1
99%
Travoprost
157283-68-6
99%
Latanoprost
130209-82-4
99%
Betaxolol hydrochloride
63659-19-8
99%
Dorzolomide hydrochloride
130693-82-2
99%
Trastuzumab
180288-69-1
97% (API grade)
Rituximab
174722-31-7
97% (API grade)
Cetuximab
205923-56-4
97% (API grade)
Etanercept
185243-69-0
97% (API grade)
Tamibarotene
94497-51-5
99%
Bexarotene
153559-49-0
99%
Vinorelbine tartrate
125317-39-7
99%
Milbemycin oxime
129496-10-2
≥98.0%
AdaliMuMab
331731-18-1
97% (API grade)
pertuzumab
380610-27-5
97% (API grade)
Abciximab
143653-53-6
97% (API grade)
Alemtuzumab
216503-57-0
97% (API grade)
Basiliximab
179045-86-4
97% (API grade)
Belimumab
356547-88-1
97% (API grade)
Bevacizumab
216974-75-3
97% (API grade)
1
2
3
4
5
6
7
8
9
10
Copyright © Wuhan Sunrise Technology Development Company Limited All rights reserved. 2012.Supported by
www.hxchem.net